Related Experiment Video
Updated: Jun 1, 2025

Neuronavigation and Laparoscopy Guided Ventriculoperitoneal Shunt Insertion for the Treatment of Hydrocephalus
Published on: October 14, 2022
Idiopathic normal pressure hydrocephalus concomitant with progressive supranuclear palsy
Tomoyo Shimada1, Anri Sakurai1, Shunichi Niiyama1
1Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan.
Introduction:
Recent studies by us and others have unveiled a frequent coexistence of idiopathic normal pressure hydrocephalus (iNPH) with neurodegenerative movement disorders, including progressive supranuclear palsy (PSP). This study aims to explore the clinical and radiological characteristics of patients with iNPH who also had comorbid with PSP, referred to as iNPHc + PSP.
Methods:
We retrospectively analyzed patients with iNPH admitted to our department between 2009 and 2024. We adhered to the established clinical criteria for iNPH and the Movement Disorder Society (MDS)-PSP criteria for probable or possible PSP with minor modifications.
Results:
Among 85 iNPH patients, 18 were categorized as having iNPHc + PSP (21.2 %). Clinically, comorbid PSP led to impaired vertical eye movement, axial-dominant parkinsonism, and a propensity to fall backward in iNPH (p = 0.022, p = 0.002, and p < 0.005, respectively). Radiologically, comorbid PSP demonstrated a shortened mesencephalic tegmentum length in the magnetic resonance imaging and an asymmetrical deficit of dopamine transporter activities in the DaTscan (p = 0.0005, p = 0.0129, respectively). Lumboperitoneal shunt (LPS) surgery improved the modified Rankin scale (p = 0.038) and the iNPH grading scale (total score, p = 0.003; gait disturbance, p = 0.020; urinary incontinence, p = 0.026) one-year after surgery.
Conclusions:
PSP can coexist with iNPH, and detailed clinical and radiological assessment can aid in detecting this comorbidity. Importantly, LPS surgery can improve outcomes of patients with iNPHc + PSP.
Related Concept Videos
Parkinson's Disease: Overview
Neural Regulation
Postsynaptic Potential (PSP)
There are two types of receptors: ionotropic and metabotropic.
The ionotropic receptor is the membrane protein that has an...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Lysosomal Hydrolases

